2,5-bis(tetrahydroxybutyl)pyrazines for the treatment of osteoarthritis and rheumatoid arthritis
申请人:ROTTAPHARM S.P.A.
公开号:EP1704862A1
公开(公告)日:2006-09-27
Use in the prevention and/or in the treatment of Osteoarthritis and Rheumatoid Arthritis of 2,5-Bis(tetrahydroxybutyl)pyrazines, compounds of formula (I), is disclosed. Compounds of the invention act simultaneously on cartilage matrix degradation and on nitric oxide and prostaglandin E2 production.
MONOMER AND COMPOSITION FOR PRODUCING LOW-PERCENTAGE HYDROGEL AND/OR HYDROGEL HAVING A LOW CROSS LINKAGE CONTENT, A HYDROGEL AND A BIOCHIP BASED THEREON
申请人:Institut Molekulyarnoi Biologii Im. V.A.
Engelgardta Rossiiskoi Akademii Nauk
公开号:EP2149581A1
公开(公告)日:2010-02-03
The invention relates to molecular biology and bioorganic chemistry, in particular to hydrogels based on cross-linked polymers with oligonucleotides, proteins, nucleic acids or any other biologically significant compounds which are immobilized therein, and to biochips which are based on the inventive hydrogels and are used in molecular biology for DNA sequencing and mapping, for detecting mutations, in analytical chemistry, for immunoassay and in many other medical applications.
本发明涉及分子生物学和生物有机化学,特别是基于交联聚合物的水凝胶,其中固定有寡核苷酸、蛋白质、核酸或任何其他具有生物意义的化合物,以及基于本发明水凝胶的生物芯片,这些生物芯片可用于分子生物学中的 DNA 测序和绘图、突变检测、分析化学、免疫测定和许多其他医学应用。